Abstract
In this article, the text in abstract which current reads: Gene expression profiling (GEP) is a tool that offers prognostic information to help assess metastatic risk and guide treatment decisions; however, prospective, nonbiased studies are needed to validate its utility to support broader integration into clinical practice. However the text should read: Gene expression profiling (GEP) is an established prognostic tool to assess the likelihood of metastasis and guide treatment decisions. The below line under “Gene Expression Profiling (GEP)” to be deleted. While it shows promise as a prognostic tool, further prospective and unbiased research is needed to support widespread implementation into clinical practice. The original article has been corrected.
Cite
CITATION STYLE
Beach, S. C., Cusick, A. S., Farberg, A. S., & Trotter, S. C. (2025, November 1). Correction: A Comprehensive Narrative Review of the Challenges Surrounding Cutaneous SCC (Dermatology and Therapy, (2025), 15, 8, (2015-2029), 10.1007/s13555-025-01470-7). Dermatology and Therapy. Adis. https://doi.org/10.1007/s13555-025-01502-2
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.